Paper7056624
Schwalbe line's cells: a new cell type in the trabecular meshwork of Macaca mulatta.
Raviola G. Invest Ophthalmol Vis Sci, 1982. Cited by 70 papers, by iCite.
Cite this record
ConductScience Library. Schwalbe line's cells: a new cell type in the trabecular meshwork of Macaca mulatta. Papers, record 7056624. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7056624
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Macaca | Major topic |
| Macaca mulatta | Major topic |
| Trabecular Meshwork | Major topic |
| Animals | |
| Cytoplasmic Granules | |
| Endoplasmic Reticulum | |
| Golgi Apparatus | |
| Microscopy, Electron |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| EY 01349 | NEI NIH HHS | United States | R01EY001349 | PubMed and NIH | NIH RePORTER |
| RR-00168 | NCRR NIH HHS | United States | P06RR000168 | PubMed and NIH | NIH RePORTER |
| P40RR000168 | NIH | NIH RePORTER | |||
| P51RR000168 | NIH | NIH RePORTER |
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42663796 | MicroRNA profiling of filtering and non-filtering regions of human trabecular meshwork: changes with ageing and in glaucoma. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42663796 | PubMed |
| 42191673 | Transforming growth factor beta-2 drives trabecular meshwork progenitor cell differentiation through SMAD2/3 signaling. | Stem Cells | 2026 | https://conductscience.org/library/papers/42191673 | PubMed |
| 39847376 | Corneal Stromal Stem Cell-Derived Extracellular Vesicles Attenuate ANGPTL7 Expression in the Human Trabecular Meshwork. | Transl Vis Sci Technol | 2025 | https://conductscience.org/library/papers/39847376 | PubMed |
| 38356373 | iPSC-derived cells stimulate ABCG2+/NES+ endogenous trabecular meshwork cell proliferation and tissue regeneration. | Cell Prolif | 2024 | https://conductscience.org/library/papers/38356373 | PubMed |
| 37495850 | iPSCs-Based Therapy for Trabecular Meshwork. | Handb Exp Pharmacol | 2023 | https://conductscience.org/library/papers/37495850 | PubMed |
| 37392960 | Posterior corneoscleral limbus: Architecture, stem cells, and clinical implications. | Prog Retin Eye Res | 2023 | https://conductscience.org/library/papers/37392960 | PubMed |
| 35398015 | A novel glaucoma approach: Stem cell regeneration of the trabecular meshwork. | Prog Retin Eye Res | 2022 | https://conductscience.org/library/papers/35398015 | PubMed |
| 35169268 | A unique pre-endothelial layer at the posterior peripheral cornea: ultrastructural study. | Sci Rep | 2022 | https://conductscience.org/library/papers/35169268 | PubMed |
| 34572584 | Replacement of the Trabecular Meshwork Cells-A Way Ahead in IOP Control? | Biomolecules | 2021 | https://conductscience.org/library/papers/34572584 | PubMed |
| 34572471 | Cell-Based Therapies for Trabecular Meshwork Regeneration to Treat Glaucoma. | Biomolecules | 2021 | https://conductscience.org/library/papers/34572471 | PubMed |
| 33506763 | Stem cell transplantation rescued a primary open-angle glaucoma mouse model. | Elife | 2021 | https://conductscience.org/library/papers/33506763 | PubMed |
| 33276809 | Regenerative capacity of the corneal transition zone for endothelial cell therapy. | Stem Cell Res Ther | 2020 | https://conductscience.org/library/papers/33276809 | PubMed |
| 33007927 | Neuroinflammation in Primary Open-Angle Glaucoma. | J Clin Med | 2020 | https://conductscience.org/library/papers/33007927 | PubMed |
| 32222223 | Generating cell-derived matrices from human trabecular meshwork cell cultures for mechanistic studies. | Methods Cell Biol | 2020 | https://conductscience.org/library/papers/32222223 | PubMed |
| 32002810 | Revisiting Existing Evidence of Corneal Endothelial Progenitors and Their Potential Therapeutic Applications in Corneal Endothelial Dysfunction. | Adv Ther | 2020 | https://conductscience.org/library/papers/32002810 | PubMed |
| 31854234 | α5β1 Integrin Promotes Anchoring and Integration of Transplanted Stem Cells to the Trabecular Meshwork in the Eye for Regeneration. | Stem Cells Dev | 2020 | https://conductscience.org/library/papers/31854234 | PubMed |
| 31641682 | Identification, quantification and age-related changes of human trabecular meshwork stem cells. | Eye Vis (Lond) | 2019 | https://conductscience.org/library/papers/31641682 | PubMed |
| 31316866 | Trabecular Meshwork Regeneration - A Potential Treatment for Glaucoma. | Curr Ophthalmol Rep | 2019 | https://conductscience.org/library/papers/31316866 | PubMed |
| 30534608 | Human stem cells home to and repair laser-damaged trabecular meshwork in a mouse model. | Commun Biol | 2018 | https://conductscience.org/library/papers/30534608 | PubMed |
| 28928631 | Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis. | Front Neurosci | 2017 | https://conductscience.org/library/papers/28928631 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7056624
GET https://conductscience.org/api/papers/v1/7056624/cited_by?page=2